We are live on
!
Find out more
EFMH
E Fund Management (HK) Portfolio holdings
AUM
$302M
1-Year Est. Return
64.42%
This Fund
S&P 500
This Quarter
Est. Return
-1.42%
1 Year Est. Return
+64.42%
3 Year Est. Return
+162.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
-$77.6M
(-26%)
Cap. Flow
-$8.42M
Cap. Flow
% of AUM
-3.83%
Top 10 Holdings %
Top 10 Hldgs %
51.43%
Holding
506
New
110
Increased
201
Reduced
59
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.07M |
| 2 |
AngloGold Ashanti
AU
|
+$1.82M |
| 3 |
Gold Fields
GFI
|
+$1.65M |
| 4 |
NVIDIA
NVDA
|
+$1.16M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atmos Energy
ATO
|
+$5.47M |
| 2 |
Newmont
NEM
|
+$3.12M |
| 3 |
Agnico Eagle Mines
AEM
|
+$2.78M |
| 4 |
Apple
AAPL
|
+$2.17M |
| 5 |
B
Barrick Mining
B
|
+$2.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.42% |
| 2 | Consumer Discretionary | 23.57% |
| 3 | Communication Services | 10.84% |
| 4 | Materials | 9.73% |
| 5 | Consumer Staples | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Cogent Biosciences
COGT
$6.65B
| $15K | 0.01% |
+389
| New | +$14.4K |
|
252
Jazz Pharmaceuticals
JAZZ
$15.9B
| $14.9K | 0.01% |
+79
| New | +$13.8K |
|
253
Takeda Pharmaceutical
TAK
$54.6B
| $14.9K | 0.01% |
+806
| New | +$14.1K |
|
254
Ecolab
ECL
$78.1B
| $14.9K | 0.01% |
56
+54
| +2,700% | +$15.2K |
|
255
Exelixis
EXEL
$13.3B
| $14.9K | 0.01% |
+347
| New | +$14.9K |
|
256
Southern Company
SO
$109B
| $14.9K | 0.01% |
154
+147
| +2,100% | +$13.6K |
|
|
NUVL
257
DELISTED
Nuvalent
NUVL
| $14.9K | 0.01% |
+145
| New | +$14.8K |
|
258
Praxis Precision Medicines
PRAX
$8.58B
| $14.8K | 0.01% |
+46
| New | +$14.2K |
|
259
Neurocrine Biosciences
NBIX
$16.8B
| $14.8K | 0.01% |
+112
| New | +$14.9K |
|
260
Krystal Biotech
KRYS
$10.1B
| $14.7K | 0.01% |
+57
| New | +$15.2K |
|
261
Equinix
EQIX
$101B
| $14.7K | 0.01% |
15
+14
| +1,400% | +$12.4K |
|
|
ABVX
262
Abivax
ABVX
$10.9B
| $14.7K | 0.01% |
+132
| New | +$15.6K |
|
263
Corteva
CTVA
$52.6B
| $14.6K | 0.01% |
175
+170
| +3,400% | +$12.8K |
|
264
Ionis Pharmaceuticals
IONS
$8.6B
| $14.6K | 0.01% |
+195
| New | +$15.4K |
|
265
argenx
ARGX
$53.4B
| $14.6K | 0.01% |
+20
| New | +$15.7K |
|
266
Hilton Worldwide
HLT
$72.1B
| $14.6K | 0.01% |
48
| – | – |
|
267
GSK
GSK
$104B
| $14.6K | 0.01% |
+264
| New | +$14.3K |
|
268
Prologis
PLD
$135B
| $14.5K | 0.01% |
110
+104
| +1,733% | +$13.9K |
|
|
FOLD
269
DELISTED
Amicus Therapeutics
FOLD
| $14.5K | 0.01% |
+1,005
| New | +$14.4K |
|
|
ACLX
270
DELISTED
Arcellx
ACLX
| $14.5K | 0.01% |
+126
| New | +$11.1K |
|
271
Kymera Therapeutics
KYMR
$8.51B
| $14.4K | 0.01% |
+173
| New | +$13.7K |
|
272
Genmab
GMAB
$17.7B
| $14.3K | 0.01% |
+533
| New | +$16K |
|
273
Celcuity
CELC
$4.21B
| $14.3K | 0.01% |
+125
| New | +$13.6K |
|
|
MRSH
274
Marsh
MRSH
$90.5B
| $14.2K | 0.01% |
82
+79
| +2,633% | +$14.2K |
|
275
Revolution Medicines
RVMD
$39.9B
| $14.2K | 0.01% |
+146
| New | +$14.7K |
|
Similar funds
GFG
PWS
TAFW
CLC
M2MC
AFGI4KRSP
GCC
WAOTB
E Fund Management (HK)'s Q1 2026 Portfolio in Review
As of Q1 2026, E Fund Management (HK) held 506 positions worth $220M, down 26% from $297M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
E Fund Management (HK) withdrew a net $8.42M in Q1 2026, closing 15 positions and reducing 59 holdings. Its most notable exit was Qfin Holdings, an estimated $636K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, E Fund Management (HK) opened a new position in AngloGold Ashanti worth $1.73M.
- E Fund Management (HK)'s largest Q1 2026 buy was AngloGold Ashanti: 17,747 shares worth $1.73M.
- E Fund Management (HK) added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.07M increase.
- E Fund Management (HK)'s biggest Q1 2026 reduction was Atmos Energy, cutting an estimated $5.47M.
- E Fund Management (HK) fully exited Qfin Holdings in Q1 2026, selling an estimated $636K.
- E Fund Management (HK)'s ten largest holdings make up 51% of its $220M portfolio in Q1 2026.
- E Fund Management (HK) opened 110 new positions and closed 15 in Q1 2026.
- E Fund Management (HK)'s portfolio value fell 26% quarter-over-quarter to $220M.
Based on E Fund Management (HK)'s 13F filing for Q1 2026, filed 8 Apr 2026.